Mosaic Advisors LLC Abb Vie Inc. Transaction History

Mosaic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $45,269 - $56,166	343 Added 13.3%	2,921 $473,000
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $329,917 - $417,441	-3,071 Reduced 54.36%	2,578 $349,000
Q3 2021 Nov 02, 2021	SELL	$106.4 - $120.78 $113,316 - $128,630	-1,065 Reduced 15.86%	5,649 $609,000
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $231,402 - $254,746	-2,262 Reduced 25.2%	6,714 $727,000
Q4 2020 Apr 23, 2021	BUY	$80.49 - $108.67 $722,478 - $975,421	8,976 New	8,976 $962,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mosaic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Mosaic Advisors LLC with notifications on news.